Original articleSix-Minute Walk Test in Patients With Down Syndrome: Validity and Reproducibility
Section snippets
Inclusion
Male and female adults with DS participated in this study. Recruitment took place in different locations: (1) patients that took part in a cardiac screening program for adults with DS. This cardiac screening program took place in The Prinsenstichting and in ASVZ, both institutions for people with intellectual disabilities, and was offered to all adults with DS living in these institutions Patients already treated by a cardiologist, patients with severe Alzheimer's disease, and patients that
Results
In total, 54 patients with DS living in the participating institutions performed the 6MWT. Ten patients were not able to perform the 6MWT because they sat in a wheelchair; 9 refused to perform the test. Twenty-seven DS patients with Eisenmenger syndrome from the outpatient clinics performed the 6MWT. Fourteen of them performed the 6MWT twice. In total, 81 adults with DS (mean age, 39±11y; 65% men) could be included in this study and were divided into 2 groups: 29 patients with severe cardiac
Discussion
In this study, we found that the 6MWD was not dependent on severity of cardiac disease in patients with DS. Therefore, the 6MWT is not a valid test to examine cardiac restriction in patients with DS. The level of intellectual disability was negatively correlated with the 6MWD and it was found to be an independent predictor of the 6MWD. The test-retest reliability of the 6MWT in patients with DS was adequate.
Conclusions
The findings of this study suggest that the 6MWT does not appear to be a valid indicator of cardiorespiratory fitness in adult patients with DS. The 6MWT appeared to be inversely related to intellectual disability in these patients. Future studies are needed to investigate other parameters that can be used to assess functional capacity in individuals with DS or modifications that can improve the validity of the 6MWT for this population.
References (29)
- et al.
A qualitative systematic overview of the measurement properties of functional walk tests used in the cardiorespiratory domain
Chest
(2001) - et al.
Reliability and feasibility of the six minute walk test in subjects with myotonic dystrophy
Neuromuscular Disorders
(2007) - et al.
Long-term effect of bosentan in adults versus children with pulmonary arterial hypertension associated with systemic-to-pulmonary shunt: does the beneficial effect persist?
Am Heart J
(2007) - et al.
Down patients with Eisenmenger syndrome: is bosentan treatment an option?
Int J Cardiol
(2009) - et al.
Heart rate variability at rest and during exercise in persons with Down syndrome
Arch Phys Med Rehabil
(2004) - et al.
The 6-minute walk test: how important is the learning effect?
Am Heart J
(2003) Guidelines for the six-minute walk test
Am J Respir Crit Care Med
(2002)- et al.
Six Minute Walk Test to assess functional capacity in chronic liver disease patients
World J Gastroenterol
(2007) - et al.
Six-minute walk test in children and adolescents
J Pediatr
(2007) - et al.
The six-minute walk test in healthy children: reliability and validity
Eur Respir J
(2005)
The six-minute walk test: normal values for children of 4-11 years of age
Arch Dis Child
Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study
Circulation
Applicability of bosentan in Dutch patients with Eisenmenger syndrome: preliminary results on safety and exercise capacity
Neth Heart J
Cardiac autonomic control in individuals with Down syndrome
Am J Ment Retard
Cited by (49)
Recent Advances in Pediatric Pulmonary Hypertension: Implications for Diagnosis and Treatment
2023, Clinical TherapeuticsAssociation between sleep quality and physical functioning in adults with Down syndrome: A brief report
2022, Disability and Health JournalCitation Excerpt :Collectively, the present and past data indicate that adults with DS have lower sleep quality than the general population. Furthermore, performances on the 6 MW and TUG were substantially lower than those reported in adults without DS34,35 and even lower than those of similarly aged adults with DS in other studies.1,2 Low levels of functional mobility in adults with DS have been found associated with their very low physical fitness.3
A single-centre, placebo-controlled, double-blind randomised cross-over study of nebulised iloprost in patients with Eisenmenger syndrome: A pilot study
2020, International Journal of CardiologyQuality of Pulmonary Function Tests in Participants with Down Syndrome
2019, Archivos de BronconeumologiaReliability and convergent validity of the 6-min run test in young adults with Down syndrome
2017, Disability and Health Journal
A commercial party having a direct financial interest in the results of the research supporting this article has conferred or will confer a financial benefit on the author or one or more of the authors. Actelion Pharmaceuticals Nederland B.V. funded the honorarium of Dr. de Bruin-Bon.